title: [Interferon alpha 2b for treatment of conjunctival melanoma: a case report].
abstract: A 71-year-old female patient with a status following multiple conjunctival excisions, histopathologically confirmed conjunctival melanoma (CMM) and also multiple therapy with mitomycin C presented with progressive conjunctival pigmentation. Treatment was carried out with local interferon α2b administration four or five times daily for several months. The lesion showed regression and lost pigmentation without any side effects.
authors: Augenabteilung, St. Franziskus Hospital, Hohenzollernring 74, 48145, Münster, Deutschland. c.schumacher@uveitis-zentrum.de
authors: C
authors: C
authors: Schumacher
authors: C
authors: C
authors: Heinz
authors: P
authors: P
authors: Lommatzsch
authors: A
authors: A
authors: Lommatzsch
authors: J
authors: J
authors: Koch
mesh_terms: D000368:Aged; D003230:Conjunctival Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins